Close
Nordic 9Nordic 9

Longitude Capital (investor - Venture Capital)

United States longitudecapital.com
See something wrong or missing? Let us know
Offices:California

Longitude Capital is a California-based venture capital firm that invests in biotechnology and medical technology companies.

Average round investment:94.66M USD
Average number per year:1.7
Distribution: 2024 (2)2022 (2)2020 (1)
Portfolio companies: Ireland FIRE1Switzerland Alentis TherapeuticsSwitzerland Opna Bio See the entire list
Mostly invests in: Switzerland Switzerland (3) Health services (5)
See the entire list

Showing 3 of 5 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Longitude Capital

Name Criteria
United States Adjuvant Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
France Malakoff Humanis
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom Norgine Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Invus
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: Switzerland, France
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
France Cemag Invest
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Switzerland Roche Venture Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Switzerland SkyViews Life Science
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland, France
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Denmark Sunstone Life Science Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland, France
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
France Xerys
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Germany 415 Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top